X
Search Filters
Format Format
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
humans (27) 27
female (21) 21
empty sella syndrome - chemically induced (13) 13
male (13) 13
middle aged (13) 13
adult (11) 11
magnetic resonance imaging (10) 10
aged (8) 8
empty sella syndrome - complications (7) 7
empty sella (6) 6
empty sella syndrome - diagnosis (6) 6
hypoglycemia - chemically induced (6) 6
index medicus (6) 6
empty sella syndrome - diagnostic imaging (5) 5
endocrinology & metabolism (5) 5
prolactinoma - drug therapy (5) 5
treatment outcome (5) 5
clinical neurology (4) 4
empty sella syndrome - etiology (4) 4
empty sella syndrome - pathology (4) 4
empty sella syndrome - surgery (4) 4
medicine & public health (4) 4
pituitary gland - pathology (4) 4
pituitary neoplasms - drug therapy (4) 4
adolescent (3) 3
endocrinology (3) 3
hypopituitarism - complications (3) 3
insulin (3) 3
optic chiasm - surgery (3) 3
surgery (3) 3
tomography, x-ray computed (3) 3
adrenal insufficiency - etiology (2) 2
adrenocorticotropic hormone - blood (2) 2
adrenocorticotropic hormone - deficiency (2) 2
atrophy - chemically induced (2) 2
bromocriptine (2) 2
bromocriptine - adverse effects (2) 2
chiasmal herniation (2) 2
child (2) 2
children (2) 2
complication (2) 2
diagnosis (2) 2
dopamine agonists - adverse effects (2) 2
dopamine agonists - therapeutic use (2) 2
empty sella syndrome (2) 2
empty sella syndrome - metabolism (2) 2
empty sella syndrome - physiopathology (2) 2
endocrine system diseases - chemically induced (2) 2
endoscopy (2) 2
ergolines - adverse effects (2) 2
ergolines - therapeutic use (2) 2
hematology (2) 2
hormone (2) 2
hormone antagonists - adverse effects (2) 2
hormones (2) 2
hydrocortisone - administration & dosage (2) 2
hydrocortisone - blood (2) 2
hydrocortisone - therapeutic use (2) 2
hypoglycemia - physiopathology (2) 2
hypopituitarism - chemically induced (2) 2
hypopituitarism - diagnosis (2) 2
hypopituitarism - etiology (2) 2
hypothalamic diseases - complications (2) 2
hypothyroidism (2) 2
hypothyroidism - drug therapy (2) 2
hypothyroidism - etiology (2) 2
insufficiency (2) 2
intracranial pressure (2) 2
medicine, general & internal (2) 2
medicine/public health, general (2) 2
metabolic diseases (2) 2
nephrotic syndrome - drug therapy (2) 2
neurosciences (2) 2
oncology (2) 2
prolactinoma (2) 2
radiography (2) 2
radiotherapy - adverse effects (2) 2
rheumatology (2) 2
thyroxine - adverse effects (2) 2
visual fields - drug effects (2) 2
-releasing hormone (1) 1
abdomen (1) 1
abnormalities (1) 1
acquired lesion (1) 1
acute myelogenous leukemia (1) 1
acute myeloid-leukemia (1) 1
adenocarcinoma of lung - pathology (1) 1
adenoma (1) 1
adenoma - pathology (1) 1
adenoma - radiotherapy (1) 1
adenoma - secretion (1) 1
adenoma, chromophobe - chemically induced (1) 1
adrenal insufficiency - chemically induced (1) 1
adrenal insufficiency - complications (1) 1
adrenal insufficiency - drug therapy (1) 1
adrenal insufficiency - pathology (1) 1
adrenal insufficiency - physiopathology (1) 1
adrenocorticotropic hormone - drug effects (1) 1
adrenocorticotropin (1) 1
adult gh deficiency (1) 1
more...
Language Language
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Acta Neurochirurgica, ISSN 0001-6268, 3/2013, Volume 155, Issue 3, pp. 495 - 496
Neurology | Surgical Orthopedics | Medicine & Public Health | Minimally Invasive Surgery | Neurosurgery | Interventional Radiology | Neuroradiology | SURGERY | PITUITARY-TUMORS | MACROPROLACTINOMA | THERAPY | MANAGEMENT | CHIASMAL HERNIATION | COMPLICATION | BROMOCRIPTINE | CLINICAL NEUROLOGY | Neoplasm, Residual - pathology | Pituitary Neoplasms - surgery | Optic Nerve - pathology | Pituitary Neoplasms - diagnosis | Humans | Optic Nerve Diseases - diagnosis | Dopamine Agonists - therapeutic use | Male | Dopamine Agonists - adverse effects | Nerve Compression Syndromes - chemically induced | Visual Fields - drug effects | Tissue Adhesions - chemically induced | Tissue Adhesions - surgery | Nerve Degeneration - chemically induced | Empty Sella Syndrome - chemically induced | Neoplasm, Residual - diagnosis | Nerve Compression Syndromes - diagnosis | Blindness - surgery | Hernia - diagnosis | Nerve Degeneration - diagnosis | Prolactinoma - drug therapy | Prolactinoma - surgery | Blindness - chemically induced | Postoperative Complications - pathology | Nerve Compression Syndromes - surgery | Optic Chiasm - surgery | Encephalocele - diagnosis | Optic Nerve Diseases - chemically induced | Empty Sella Syndrome - surgery | Nerve Degeneration - surgery | Blindness - diagnosis | Encephalocele - chemically induced | Encephalocele - surgery | Optic Nerve Diseases - surgery | Postoperative Complications - diagnosis | Hernia - chemically induced | Prolactinoma - diagnosis | Magnetic Resonance Imaging | Empty Sella Syndrome - diagnosis | Frontal Lobe - surgery | Pituitary Neoplasms - drug therapy | Frontal Lobe - drug effects | Optic Nerve - surgery | Tissue Adhesions - diagnosis | Craniotomy | Optic Chiasm - pathology | Frontal Lobe - pathology | Optic Chiasm - drug effects
Journal Article
Journal Article
Leukemia Research, ISSN 0145-2126, 2006, Volume 31, Issue 8, pp. 1135 - 1139
Journal Article
Journal Article
Journal Article
Internal Medicine, ISSN 0918-2918, 2016, Volume 55, Issue 18, pp. 2649 - 2658
A 73-year-old Japanese woman with untreated Graves' hyperthyroidism developed glucocorticoid-induced adrenal insufficiency (AI) after a supraphysiological dose... 
type 2 diabetes mellitus, empty sella turcica | Graves' disease, bronchial asthma | glucocorticoid-induced adrenal insufficiency | isolated adrenocorticotropin deficiency | Glucocorticoid-induced adrenal insufficiency | Bronchial asthma | Type 2 diabetes mellitus | Empty sella turcica | Graves’ disease | Isolated adrenocorticotropin deficiency | MEDICINE, GENERAL & INTERNAL | PEPTIDES | HORMONE | Graves' disease | type 2 diabetes mellitus | empty sella turcica | INSUFFICIENCY | bronchial asthma | PITUITARY-ADRENAL AXIS | ISOLATED ACTH DEFICIENCY | Prednisolone - adverse effects | Glucocorticoids - therapeutic use | Endocrine System Diseases - chemically induced | Adrenocorticotropic Hormone - drug effects | Humans | Graves Disease - drug therapy | Hydrocortisone - therapeutic use | Anorexia - drug therapy | Genetic Diseases, Inborn - chemically induced | Adrenocorticotropic Hormone - deficiency | Female | Prednisolone - therapeutic use | Graves Disease - physiopathology | Hydrocortisone - blood | Hypoglycemia - chemically induced | Adrenocorticotropic Hormone - blood | Anorexia - blood | Glucocorticoids - adverse effects | Fatigue - drug therapy | Antithyroid Agents - therapeutic use | Fatigue - blood | Treatment Outcome | Asthma - drug therapy | Adrenal Insufficiency - physiopathology | Adrenal Insufficiency - chemically induced | Adrenal Insufficiency - drug therapy | Graves Disease - complications | Aged
Journal Article
Endocrine practice : official journal of the American College of Endocrinology and the American Association of Clinical Endocrinologists, ISSN 1530-891X, 2003, Volume 9, Issue 2, pp. 147 - 151
Journal Article
No results were found for your search.

Cannot display more than 1000 results, please narrow the terms of your search.